Search results
Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
Zacks via Yahoo Finance· 2 days agoNovartis NVS announced new long-term efficacy and safety data from the late-stage studies REMIX-1...
Novartis (NVS) Announces Positive Data on Oncology Drug
Zacks via Yahoo Finance· 2 years agoNovartis' (NVS) anti-PD-1 monoclonal antibody, tislelizumab, significantly extends median overall...
Pharma Stock Roundup: NVS to Spin Off Sandoz; JNJ, MRK, ABBV's FDA Updates
Zacks via Yahoo Finance· 2 years agoNovartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 1 month agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
Zacks via Yahoo Finance· 6 months agoThis week, AbbVie ABBV announced a definitive agreement to acquire cancer biotech Immunogen at a...
The Zacks Analyst Blog Highlights Novartis, Duke Energy, Boston Scientific, Norfolk Southern and...
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – August 1, 2022 – Zacks.com announces the list of stocks featured...
With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial
Benzinga via Yahoo Finance· 2 years agoNovartis AG (NYSE: NVS) suspended dosing in a Huntington's disease study because early signs of side...
Why Precision BioSciences Shares Are Surging Today
Benzinga via Yahoo Finance· 2 years agoPrecision BioSciences Inc (NASDAQ: DTIL) has entered into an exclusive worldwide in vivo gene editing research and development collaboration and license...
Novartis AG's Dividend Analysis
GuruFocus.com via Yahoo Finance· 3 months agoNovartis AG (NYSE:NVS) recently announced a dividend of $3.78 per share, payable on a date yet to be announced, with the ex-dividend date set for...
Gilead (GILD) Up 2.6% in 3 Months: Will the Momentum Continue?
Zacks via Yahoo Finance· 2 years agoShares of Gilead Sciences, Inc. GILD has gained 2.6% in the past three months against the industry’s...